Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data From an Observational Study
Ophthalmology - Netherlands
doi 10.1016/j.ophtha.2016.08.016
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2016
Authors
Publisher
Elsevier BV